NASDAQ:IMRX | Cash Flow Statement | Immuneering Corp

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$17.27M$84,454.00
2026-03-31-$13.46M$81,402.00-$18.43M$79,930.00-$63.07M$180,760.00
2025-12-31-$11.58M$75,889.00-$9.84M$123,910.00-$88.72M-$357,523.00
2025-09-30-$14.96M$78,841.00
2025-06-30-$14.43M$84,527.00
2025-03-31-$15.05M$85,261.00-$14.08M$8,945.00-$8,945.00$13.81M
2024-12-31-$18.05M$86,116.00-$14.51M$9,356.00$5.49M-$40,988.00
2024-09-30-$14.6M$88,949.00
2024-06-30-$14.08M$90,533.00
2024-03-31-$14.31M$90,209.00-$15.49M$37,478.00$21.39M$979,923.00
2023-12-31-$15.08M$89,754.00-$11.78M$170,918.00$3.13M$7,835.00
2023-09-30-$12.6M$78,294.00
2023-06-30-$12.19M$78,242.00
2023-03-31-$13.6M$76,527.00-$14.42M$27,993.00$18.97M$239,408.00
2022-12-31-$13.25M-$11.75M$69,302.00$8.15M-$184,677.00
2022-09-30-$12.84M$68,075.00
2022-06-30-$11.53M$54,560.00
2022-03-31-$12.9M-$12.28M$115,050.00$12.4M$193,111.00
2021-12-31-$10.78M-$9.24M$13,052.00-$22.81M$7,519.00
2021-09-30-$8.53M
2021-06-30-$7.99M
2021-03-31-$6.23M-$6.14M$16,564.00-$16,564.00
2020-12-31-$5.84M-$5.45M$38,058.00-$38,058.00$36.98M
2020-09-30-$4.4M
2020-06-30-$3.6M
2020-03-31-$3.2M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$56.02M$324,517.00-$45.34M$142,226.00-$88.74M$226.58M
2024-12-31-$61.04M$355,807.00-$55M$84,875.00$26.43M$5.3M
2023-12-31-$53.47M$322,816.00-$48.97M$342,746.00$7.3M$28.44M
2022-12-31-$50.51M-$44.1M$742,483.00$41.83M$19,004.00
2021-12-31-$33.54M-$30.85M$60,786.00-$75.62M$144.26M
2020-12-31-$17.04M-$14.62M$53,415.00-$53,415.00$37.98M